• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

J&J targets 2024 for Ottava FDA filing

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 07, 2023 at 11:23: PM
via The company expects to file a submission for an investigational device exemption in the second half of 2024 that will allow it to begin clinical trials for the robotic surgery system.

article source
 




Top Bottom
Back
Quote